Skip to content

Scientific Technology News

About STN
Contact Us

Top-10
Instrument Industry Deals
Product Launches

Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older

August 12, 2022September 7, 2022 by /

Share This.....

Share on linkedin

Share on twitter

Share on facebook

Share on google

Related News:

Roche announces the European Commission approval of…
CHMP recommends EU approval of Ronapreve to treat…
CHMP recommends EU approval of Actemra/RoActemra to…
FDA approves Roche’s Vabysmo, the first bispecific…
FDA approves Roche’s Vabysmo, the first bispecific…
FDA approves Roche’s Lunsumio, a first-in-class…

Share this:

Click to share on Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)

Category: Acad, Gov/Utilities, Bio/Pharma/CRO Tag: Roche

Post navigation

Previous PostImproving the Working Environment and Reducing Environmental impacts by Digital transformation of the Production Lines—Shimane Shimadzu Corporation, The Medical System Manufacturing Subsidiary of Shimadzu Co.—

Next PostBruker Announces Quarterly Dividend

Get market data and industry analysis here. Request a complimentary copy.

Related News

Roche announces the European Commission approval of… January 12, 2023
CHMP recommends EU approval of Ronapreve to treat… November 11, 2021
CHMP recommends EU approval of Actemra/RoActemra to… December 6, 2021
FDA approves Roche’s Vabysmo, the first bispecific… January 31, 2022
FDA approves Roche’s Vabysmo, the first bispecific… January 31, 2022
FDA approves Roche’s Lunsumio, a first-in-class… December 23, 2022
Roche’s Actemra/RoActemra receives U.S. FDA… June 25, 2021
GE Healthcare and Wayra select five AI-led… June 24, 2021
GE Healthcare’s Industry-First Contrast-Guided… July 7, 2021
Ronapreve approved by European Commission to treat… November 12, 2021

© 2024 Scientific Technology News